Aurinia Pharmaceuticals Inc.AUPHNASDAQ
LOADING
|||
Switch Symbol:
EBITDA Over Time
Trending higher, above historical average.
Left:
||||
Earnings before interest, taxes, depreciation, and amortization
Latest
$31.73M
↑ 149% above average
Average (9y)
$-64.80M
Historical baseline
Range
High:$31.73M
Low:$-177.44M
CAGR
NaN%
Modest growth trend
| Period | Value | Change |
|---|---|---|
| 2024 | $31.73M | +150.3% |
| 2023 | $-63.05M | +39.2% |
| 2022 | $-103.65M | +41.6% |
| 2021 | $-177.44M | -72.4% |
| 2020 | $-102.92M | -14.6% |
| 2019 | $-89.77M | -66.5% |
| 2018 | $-53.93M | -18.2% |
| 2017 | $-45.61M | -113.8% |
| 2016 | $-21.34M | +3.1% |
| 2015 | $-22.02M | - |